Provided by Tiger Trade Technology Pte. Ltd.

Erasca, Inc.

17.63
+0.55003.22%
Post-market: 17.640.0100+0.06%19:48 EDT
Volume:2.45M
Turnover:43.10M
Market Cap:6.17B
PE:-18.16
High:17.84
Open:17.28
Low:17.21
Close:17.08
52wk High:24.28
52wk Low:1.33
Shares:349.76M
Float Shares:291.15M
Volume Ratio:0.97
T/O Rate:0.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9710
EPS(LYR):-0.4393
ROE:-78.25%
ROA:-21.39%
PB:17.04
PE(LYR):-40.14

Loading ...

Erasca Q1 EPS $(0.60) Misses $(0.22) Estimate

Benzinga Earnings
·
May 12

Erasca reports Q1 EPS (60c), consensus (23c)

TIPRANKS
·
May 12

Erasca Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

Erasca Q1 FY26 net loss widens to $183.4 million###

Reuters
·
May 12

Erasca Q1 Basic EPS USD -0.6

THOMSON REUTERS
·
May 12

Erasca Reports First Quarter 2026 Business Updates and Financial Results

GlobeNewswire
·
May 12

BUZZ-U.S. STOCKS ON THE MOVE-Barrick Mining, Lumentum, Tesla

Reuters
·
May 12

Erasca enters AURORAS-1 clinical trial pact, supply agreement with Merck

TIPRANKS
·
May 12

BUZZ-U.S. STOCKS ON THE MOVE-Moderna, Beazer Homes, Lumentum

Reuters
·
May 11

BUZZ-U.S. STOCKS ON THE MOVE-Liquidia, Target Hospitality, oil companies

Reuters
·
May 11

Erasca Teams With Merck on AURORAS-1 Cancer Study

MT Newswires Live
·
May 11

BUZZ-U.S. STOCKS ON THE MOVE-Philip Morris, Circle, Erasca

Reuters
·
May 11

Erasca Shares up 7.8% Premarket After Co and Merck Collaborate to Test Cancer Drug Combo

THOMSON REUTERS
·
May 11

BUZZ-Erasca rises after Merck cancer drug combo pact

Reuters
·
May 11

Erasca partners with Merck to test ERAS-0015-Keytruda combo in RAS-mutant tumors

Reuters
·
May 11

Erasca Inc - Auroras-1 Study to Evaluate Eras-0015 With Keytruda in Ras-Mutant Solid Tumors

THOMSON REUTERS
·
May 11

Erasca Inc - Co to Sponsor Study; Merck to Supply Pembrolizumab at No Cost

THOMSON REUTERS
·
May 11

Erasca Announces Clinical Trial Collaboration and Supply Agreement With Merck to Evaluate Eras-0015 in Combination With Keytruda® (Pembrolizumab)

THOMSON REUTERS
·
May 11

Erasca Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate ERAS-0015 in Combination with KEYTRUDA® (Pembrolizumab)

GlobeNewswire
·
May 11

Erasca to present at Bank of America Securities Health Care Conference

Reuters
·
May 06